PREFORMED IGG ANTIBODIES AGAINST MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II ANTIGENS ARE MAJOR RISK-FACTORS FOR HIGH-GRADE CELLULAR REJECTION IN RECIPIENTS OF HEART-TRANSPLANTATION
S. Itescu et al., PREFORMED IGG ANTIBODIES AGAINST MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II ANTIGENS ARE MAJOR RISK-FACTORS FOR HIGH-GRADE CELLULAR REJECTION IN RECIPIENTS OF HEART-TRANSPLANTATION, Circulation, 98(8), 1998, pp. 786-793
Citations number
26
Categorie Soggetti
Peripheal Vascular Diseas",Hematology,"Cardiac & Cardiovascular System
Background-Preformed anti-HLA antibodies reacting specifically with do
nor lymphocytes have been associated with acute vascular rejection and
early cardiac allograft failure. However, the effect of preformed ant
i-HLA antibodies directed against allogeneic major histocompatibility
complex (MHC) class I or II antigens of a donor panel on heart transpl
antation outcome has not been extensively studied. Methods and Results
-The study group consisted of 68 patients who received cardiac transpl
ants between 1989 and 1996 and who were at high risk for developing an
ti-HLA antibodies before transplantation. The effect of preformed anti
bodies against allogeneic MHC class I or class II antigens on the deve
lopment of early high-grade cellular rejection and on cumulative annua
l rejection frequency was determined. Both patients with left ventricu
lar assist devices and retransplantation candidates had a similar incr
ease in the frequency of IgG anti-MHC class LI antibodies (IgG anti-II
) compared with control subjects (P<0.0001), whereas the frequency of
IgG anti-MHC class I antibodies (IgG anti-I) was elevated only in pati
ents with left ventricular assist devices. Pretransplantation IgG anti
-II predicted early development of high-grade cellular rejection (P=0.
006) and higher cumulative annual rejection frequency (P<0.001) in bot
h of these sensitized patient groups. Among retransplantation recipien
ts, a match between donors 1 and 2 at HLA-A additionally predicted an
earlier time to a high-grade cellular rejection. Conclusions-These res
ults emphasize the importance of specifically screening heart transpla
ntation candidates for the presence of IgG antibodies directed against
MHC class IT molecules and suggest that strategies aimed at their red
uction may have an impact on the onset and frequency of high-grade cel
lular rejections after transplantation.